Product Information
ROSUVASTATIN CALCIUM 5 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.0350 per EA under NDC 16729028415. Its NADAC has been published 496 times since Nov 23, 2016.
FDA first approved this application on Oct 31, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729028415
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
ROSUVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206434FDA Approved
10/31/2016
TE Code
AB
On Market Since
10/31/2016
Pharmacological Classes
Price Statistics
The NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has been published 496 times since Nov 23, 2016, and over the history we have for it it has declined 88.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0350 per EA |
|---|---|
| All-time high | $0.3040 (Jan 11, 2017) |
| All-time low | $0.0341 (Nov 20, 2024) |
| 52-week high | $0.0389 |
| 52-week low | $0.0341 |
| Median price | $0.0779 |
| Average price | $0.0834 |
| Largest weekly change | -24.9% (Jan 18, 2017) |
| Weeks tracked | 496 |
| Tracking since | Nov 23, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
+2.4%
1Y
-10.2%
3Y
-28.8%
5Y
-57.8%
All
-88.4%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROSUVASTATIN CALCIUM 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 5 MG TAB, manufactured by Accord Healthcare Inc., is $0.0350 per EA (NDC 16729028415), effective May 20, 2026.
How has the price of ROSUVASTATIN CALCIUM 5 MG TAB changed over time?
Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has declined 88.4%. It has been tracked across 496 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 5 MG TAB?
Since Nov 23, 2016, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has ranged from a low of $0.0341 (Nov 20, 2024) to a high of $0.3040 (Jan 11, 2017), with a median of $0.0779 per EA.
Are there cheaper alternatives to ROSUVASTATIN CALCIUM 5 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ROSUVASTATIN CALCIUM 5 MG TAB, is $0.0333 per EA — about 5% below ROSUVASTATIN CALCIUM 5 MG TAB.
Who manufactures ROSUVASTATIN CALCIUM 5 MG TAB?
ROSUVASTATIN CALCIUM 5 MG TAB (NDC 16729028415) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.